Form D · Biotechnology
Advanced Medical Technologies LLC
New York, NY · CIK 0001697584
Offering snapshot reported Feb 10, 2017 · SEC filing
- Reported sold
- $0 Offering amount: $20M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $500K Reported outside-investor minimum
- First sale
- Feb 8, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 10, 2017 | Initial | $0 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-280506
Source: Form D, filed Feb 10, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Daniel Bejarano | Director |
| Nathan Milikowsky | Director |
| Michael Nahl | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
145 Central Park West #15 C
New York, NY, 10023
New York, NY, 10023